Live Breaking News & Updates on Asia Pacific Market Size

Stay updated with breaking news from Asia pacific market size. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Worldwide HIV Drugs Industry to 2027 - Impact Analysis of COVID-19


Share this article
Share this article
ResearchAndMarkets.com s offering.
The global HIV drugs market was valued at $30,891.48 million in 2019, and is expected to reach $36,495.47 million by 2027, registering a CAGR of 3.8% from 2020 to 2027.
Human immunodeficiency virus (HIV) attacks the body s immune system, leading to complete damage of the system and making the host system susceptible to infection. The virus attacks the CD4 cells, whose primary role is to help the immune system defend infections, thus destroying the first line of defense of the human body and exposing the person to various infections. HIV is one of the most alarming and widespread diseases globally. The major route of transmission of HIV infection is through unprotected sex, use of contaminated needles, breast milk of HIV-infected mother to child, and infected blood. ....

United States , United Kingdom , South Africa , Saudi Arabia , Prezcobix Prezista , Laura Wood , Merck Co , Gilead Sciences Inc , Teva Pharmaceutical Industries Ltd , Merck Co Inc , Pfizer Inc , Abbvie Inc , Boehringer Ingelheim International Gmb , Porter Five Forces Analysis , Roche Ltd , Company Overview , Cipla Inc , Office Hours Call , Research Methodology , Company Profiles , E St Office Hours Call , Company Snapshot , Market By Medication Class , Non Nucleoside Reverse Transcriptase Inhibitors , Strand Transfer Inhibitors , Opportunity Analysis ,